Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-135343)

Filing Details

Accession Number:: 0001209191-16-135343
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-03 20:04:13
Reporting Period:: 2016-08-01

Filing Date:: 2016-08-03
Accepted Time:: 2016-08-03 20:04:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222788	John Tamerius	12544 High Bluff Drive, Suite 200 San Diego CA 92130	Svp, Strat & Ext Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-08-01	7,000	$23.02	18,540	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The weighted average sale price for these transactions was $23.0177 per share, with a range of $23.00 to $23.13 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.